Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
---|---|---|---|
6/30/2025 | $ 1.55M | $ 362.57M | 233.77 |
3/31/2025 | $ -5.3M | $ 527.19M | 0 |
12/31/2024 | $ -11.1M | $ 464.24M | 0 |
9/30/2024 | $ -27.46M | $ 347.19M | 0 |
6/30/2024 | $ -47.62M | $ 565.28M | 0 |
3/31/2024 | $ -80.45M | $ 591.1M | 0 |
12/31/2023 | $ -110.06M | $ 505.73M | 0 |
9/30/2023 | $ -118.87M | $ 226.18M | 0 |
6/30/2023 | $ -135.77M | $ 355.21M | 0 |
3/31/2023 | $ -150.07M | $ 396.8M | 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / EBIT
(=) EV/EBIT
EV/EBIT for HERON THERAPEUTICS INC is calculated as follows: EV [ $ 1.5B ] / EBIT [ $ -228.7M ]
(=) EV/EBIT [ 0 ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0.05 |
max | 62.03 |
average | 19.91 |
median | 16.78 |
std | 12.32 |